A Multicenter Double-blind Randomized Sham-controlled Trial Assessing the EndoBarrier Duodenal-jejunal Bypass Liner for the Treatment of Poorly Controlled type 2 Diabetes Mellitus with Concomitant Obesity: The ENDO Trial.

Journal:
Annals of Surgery
Published:
DOI:
10.1097/sla.0000000000006974
Affiliations:
14
Authors:
15
Go to article
Institutions Authors Share
Brigham and Women's Hospital (BWH), United States of America (USA)
3.000000
 0.20
Mayo Clinic, United States of America (USA)
1.000000
 0.07
Pennington Biomedical Research Center (PBRC), LSU, United States of America (USA)
1.000000
 0.07
University of Colorado Denver (CU Denver), United States of America (USA)
1.000000
 0.07
The University of Texas Health Science Center at Houston (UTHealth), United States of America (USA)
1.000000
 0.07
Cleveland Clinic, United States of America (USA)
1.000000
 0.07
Houston Methodist Hospital, United States of America (USA)
1.000000
 0.07
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)
1.000000
 0.07
The Oregon Clinic, United States of America (USA)
1.000000
 0.07
Carolinas Medical Center (CMC), Atrium Health, United States of America (USA)
1.000000
 0.07
The Ohio State University (OSU), United States of America (USA)
1.000000
 0.07
University of Michigan (U-M), United States of America (USA)
1.000000
 0.07
Salem VA Medical Center, United States of America (USA)
0.500000
 0.03
Carilion Roanoke Memorial Hospital, United States of America (USA)
0.500000
 0.03
Interested in Clinical Sciences?